BTIG analyst Vincent Caintic maintained a Buy rating on Affirm Holdings (AFRM – Research Report) yesterday and set a price target of $81.00.

BTIG analyst Janine Stichter maintained a Buy rating on Lululemon Athletica (LULU – Research Report) today and set a price target of $470.00.

Analysts at BTIG moved to the sidelines on online dating apps company Match Group (NASDAQ:MTCH) and lowered its investment ...

The economic fundamentals of Wednesday's inflation report will doubtless impact stocks. But before that let's have a chartist view from BTIG's technical guru Jonathan Krinsky. He notes that the S&P 50 ...

Match's valuation is also a concern. At 10x EBITDA with declining revenue, the multiple is seen as "full," limiting upside ...

Fintel reports that on January 10, 2025, BTIG initiated coverage of ImmunityBio (NasdaqGS:IBRX) with a Buy recommendation.

DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company's ...

In recent trading, P3 Health Partners Inc (PIII) stock price has shown some volatility, fluctuating -13.35% over the last five trades a ...

Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Inari Medical (NasdaqGS:NARI) from Buy to Neutral.

Palo Alto Networks Inc (PANW) stock saw a modest uptick, ending the day at $170.58 which represents a slight increase of $2.76 or 1.64% from the prior close of $167.82. The stock opened at $168.3 and ...

Genius Sports Limited (NYSE: GENI) (“Genius Sports,” the “Company,” “we” or “our”) announced today the pricing of an underwritten public offering of 1 ...

On Friday, BTIG initiated coverage on ImmunityBio Inc (NASDAQ:IBRX) with a Buy rating and a price target of $6.00. The firm sees potential in the company's lead product, ANKTIVA, an IL-15 receptor ...